Human Cell Transformation Advances in Cell Models for the Study of Cancer and Aging /
This book, part contributed volume, part proceedings, discusses state-of-the-art advances on human cell transformation in cell models for the study of cancer and aging. Several of the chapters are from the Human Cell Transformation: Advances in Cell Models for the Study of Cancer and Aging conferenc...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 1st ed. 2019. |
Σειρά: | Advances in Experimental Medicine and Biology,
1164 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Mechanisms underlying metastatic pancreatic cancer
- Current Perspectives on Nasopharyngeal Carcinoma
- An in Vitro Model of Triple Negative Breast cancer
- Emerging role of novel biomarkers of Ly6 gene family in pan cancer
- The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy
- Contributing roles of CYP2E1 and other cytochrome P450 isoforms in alcohol-related carcinogenesis
- Novel Human Prostate Epithelial Cell Cultures
- African American Prostate Normal and Cancer Cells for Health Disparities Research
- Assessing the Advantages, Limitations and Potential of Human Primary Prostate Epithelial Cells as a Pre-Clinical Model for Prostate Cancer Research
- Role of alternative splicing in prostate cancer aggressiveness and drug resistance in African Americans
- Research Article: Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer Patients
- The Aging Skeleton
- Parathyroid Hormone Related Protein (PTHrP): an Emerging Target in Cancer Progression and Metastasis
- Targeting DNA hypomethylation in malignancy by epigenetic therapies
- Tumor Dormancy and Slow-Cycling Cancer Cells
- Resolution of Cellular Heterogeneity in Human Prostate Cancers: Implications for Diagnosis and Treatment
- Small molecule inhibition of glycogen synthase-kinase 3 in cancer immunotherapy.